- Home
- LAZR vs INBX Comparison
LAZR vs INBX Comparison
Compare LAZR & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAZR
- INBX
- Stock Information
- Founded
- LAZR 2012
- INBX 2010
- Country
- LAZR United States
- INBX United States
- Employees
- LAZR N/A
- INBX N/A
- Industry
- LAZR Auto Parts:O.E.M.
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- LAZR Consumer Discretionary
- INBX Health Care
- Exchange
- LAZR Nasdaq
- INBX Nasdaq
- Market Cap
- LAZR 215.6M
- INBX 178.5M
- IPO Year
- LAZR N/A
- INBX 2020
- Fundamental
- Price
- LAZR $3.03
- INBX $16.33
- Analyst Decision
- LAZR Hold
- INBX Hold
- Analyst Count
- LAZR 7
- INBX 1
- Target Price
- LAZR $37.83
- INBX N/A
- AVG Volume (30 Days)
- LAZR 3.1M
- INBX 84.1K
- Earning Date
- LAZR 08-05-2025
- INBX 08-12-2025
- Dividend Yield
- LAZR N/A
- INBX N/A
- EPS Growth
- LAZR N/A
- INBX N/A
- EPS
- LAZR N/A
- INBX 111.58
- Revenue
- LAZR $73,313,000.00
- INBX $200,000.00
- Revenue This Year
- LAZR $16.38
- INBX N/A
- Revenue Next Year
- LAZR $30.37
- INBX N/A
- P/E Ratio
- LAZR N/A
- INBX $0.15
- Revenue Growth
- LAZR N/A
- INBX N/A
- 52 Week Low
- LAZR $2.52
- INBX $10.80
- 52 Week High
- LAZR $32.70
- INBX $17.79
- Technical
- Relative Strength Index (RSI)
- LAZR 45.89
- INBX 68.23
- Support Level
- LAZR $2.73
- INBX $13.97
- Resistance Level
- LAZR $3.05
- INBX $15.25
- Average True Range (ATR)
- LAZR 0.17
- INBX 0.75
- MACD
- LAZR 0.05
- INBX 0.06
- Stochastic Oscillator
- LAZR 91.15
- INBX 99.16
About LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and Advanced Technologies and Services. The majority of its revenue is generated from the Autonomy Solutions segment, which engages in the design, manufacturing, and sale of LiDAR sensors, catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries. The Advanced Technologies and Services segment provides semiconductors and related components, as well as design, test, and consulting services to the Autonomy Solutions segment and various third-party customers. Geographically, the company derives its key revenue from North America.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.